InvestorsHub Logo

Zuess421

04/28/20 4:23 PM

#71910 RE: BreezeWoodAcres #71908

I believe they have trademarked many different names and all will be sold under different names for pricing purposes.

Scooter McCabe

04/28/20 4:35 PM

#71915 RE: BreezeWoodAcres #71908

It's the same drug. The price would be based upon the amount of dosage if there is going to be any variation. Since it is one drug treating so many things the price will naturally be higher than other drugs because of the demand coming from multiple medical issues.

Monroe1

04/28/20 6:26 PM

#71934 RE: BreezeWoodAcres #71908

Since all this is coming together at about the same time ... COVID and HIV studies, it could be either they share the same label, or different containers/labels/trademarks. The FDA will determine this.

[Also, I would suppose as an example we will see at some point the manufacturers of HCquine adding COVID 19 with the others... Malaria, Lupus etc to the labels of that HCQ product.]

For those trials that are for specific indications are unique and in different phases of study, I would assume they each are considered separately with having different names and pricing.